ALDH1A1 and melanoma: A whole-cell melanoma vaccine genetically modified toward a CSC phenotype characterized by high levels of ALDH1 (AGI-101H) was applied in advanced melanoma patients, with resected and non-resected tumors, and combined with surgery in patients with recurring metastases.